Thu, Apr 27, 2017
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Niederhoffer initiate and UK finance professor launches hedge fund

Wednesday, July 11, 2012

amb
Victor Niederhoffer
By Beverly Chandler, Opalesque London:

A rounded 15 year career, starting in private banking, moving on to work with one of the original hedge fund managers, Victor Niederhoffer, and then on through the ups and downs of life in the City of London within banks and hedge fund firms through the financial crisis, has prepared Patrick Boyle for his next role, managing Palomar Fund Management.

Boyle is to launch Palomar in September of this year, with $50m under management, partly seeded by distinguished names from the hedge fund industry, an institution, a family office and from his own capital.

He started as a 21 year old in the private banking sector, observing and studying money management and realising that his biggest problem in getting on was a total lack of experience. With the arrival of all market data in the public domain at the end of the 1990s, Boyle started to study. "I thought it might be a smart approach if I analysed as much data as possible so I could speak knowledgeably about stocks; even if I hadn�t lived through the various periods, I could at least be a history student of the market."

The studies became more statistical in their nature and he enjoyed a couple of early successes, applying his theories to investment. "I realised over time that certain rules work better than others" he says. "I initially approached the markets like a man from Mars and in a way that is why I developed my own approach."

He read of Niederhoffer, admired his ......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing

 



  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Alternative asset firm YieldStreet surpasses $100m of loans funded in less than 8 quarters[more]

    Komfie Manalo, Opalesque Asia: Alternative asset investment platform YieldStreet reported that it has surpassed $100m in loans funded in less than eight quarters from accredited investors and single family offices. YieldStreet was founded by Milind Mehere and Michael Weisz. In a

  2. Investing - Investor appetite for high-growth IPOs to be tested, Apollo boosts fund's stock allowance for 'diamonds in the rough', Hedge funds uncertain over outlook for Hargreaves Lansdown[more]

    Investor appetite for high-growth IPOs to be tested From FT.com: The US listings market is poised for a busy week with deals that will test investors' appetite for high-growth - but lossmaking - companies. Eight new listings are scheduled for this week, the most since October of 2016,

  3. Hedge funds holding Puerto Rico bonds are looking at a long battle[more]

    Komfie Manalo, Opalesque Asia: Hedge funds which bought Puerto Rico's distressed debt bonds are facing the prospect of a long road ahead to recover their investments as the Caribbean island is attempting to use a U.S. Congress-approved rule that allows it to exploit a bankruptcy-like proceedings

  4. Other Voices: "Winner-take-all" dynamics and hedge fund investing[more]

    A growing stream of thinking in microeconomics is the concept of "winner-take-all" dynamics. The idea seems simple. A combination of networking economics and classic economies of scale creates situations where there are just a few dominant firms or economic agents who are able to capture significant

  5. Investing - How Chipotle's comeback attracted big data robots and value investors alike[more]

    From Forbes.com: When William Ackman's ailing hedge fund Pershing Square Capital Management bet $1 billion on shares in Chipotle Mexican Grill beginning in July 2016, the stakes couldn't have been higher. Pershing Square was reeling from what would eventually be a near $4 billion loss in drugmaker V